BUZZ-Australia's Next Science plunges on litigation filed by ex-employee

Reuters

2025/01/08

** Next Science NXS.AX slumps as much as 13% to record low of A$0.1; set for weakest trading session since October 2024

** Medical tech firm says a former employee filed litigation in the U.S., alleging breaches of fiduciary duties and mismanagement against several employees

** Litigation makes several claims - that certain tech has not been approved by U.S. FDA and that co did not take sufficient measures to address safety concerns about the use of its surgical solution in breast implant procedures

** Co says its products are safe, effective and FDA-approved

** Stock fell 66.2% in 2024

(Reporting by Manasi Dasa Sundeep in Bengaluru)

((manasi.dasasundeep@thomsonreuters.com))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2501102761"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2501102761\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2501102761?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-08 10:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501102761","market":"us","top_or_hot":-1,"title":"BUZZ-Australia's Next Science plunges on litigation filed by ex-employee","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's Next Science plunges on litigation filed by ex-employee</title></head><body><p>** Next Science <span>NXS.AX</span> slumps as much as 13% to record low of A$0.1; set for weakest trading session since October 2024</p><p>** Medical tech firm <span>says</span> a former employee filed litigation in the U.S., alleging breaches of fiduciary duties and mismanagement against several employees</p><p>** Litigation makes several claims - that certain tech has not been approved by U.S. FDA and that co did not take sufficient measures to address safety concerns about the use of its surgical solution in breast implant procedures</p><p>** Co says its products are safe, effective and FDA-approved</p><p>** Stock fell 66.2% in 2024</p><p> (Reporting by Manasi Dasa Sundeep in Bengaluru)</p><p> ((manasi.dasasundeep@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Australia's Next Science plunges on litigation filed by ex-employee</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Australia's Next Science plunges on litigation filed by ex-employee\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-01-08 10:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's Next Science plunges on litigation filed by ex-employee</title></head><body><p>** Next Science <span>NXS.AX</span> slumps as much as 13% to record low of A$0.1; set for weakest trading session since October 2024</p><p>** Medical tech firm <span>says</span> a former employee filed litigation in the U.S., alleging breaches of fiduciary duties and mismanagement against several employees</p><p>** Litigation makes several claims - that certain tech has not been approved by U.S. FDA and that co did not take sufficient measures to address safety concerns about the use of its surgical solution in breast implant procedures</p><p>** Co says its products are safe, effective and FDA-approved</p><p>** Stock fell 66.2% in 2024</p><p> (Reporting by Manasi Dasa Sundeep in Bengaluru)</p><p> ((manasi.dasasundeep@thomsonreuters.com))</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NXS.AU","symbol_name":"NEXT SCIENCE LTD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nL4N3O403L:1","article_id":"2501102761","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501102761","pubTimestamp":1736301698,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Australia's Next Science plunges on litigation filed by ex-employee** Next Science NXS.AX slumps as much as 13% to record low of A$0.1; set for weakest trading session since October 2024** Medical tech firm says a former employee filed litigation in the U.S., alleging breaches of fiduciary duties and mismanagement against several employees** Litigation makes several claims - that certain tech has not been approved by U.S. FDA and that co did not take sufficient measures to address safety concerns about the use of its surgical solution in breast implant procedures** Co says its products are safe, effective and FDA-approved** Stock fell 66.2% in 2024  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NXS.AU":"NEXT SCIENCE LTD","BK7126":"医疗保健用品"},"translate_title":"BUZZ-澳大利亚Next Science因前雇员提起诉讼而暴跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NXS.AU":0.9},"content_text":"BUZZ-Australia's Next Science plunges on litigation filed by ex-employee** Next Science NXS.AX slumps as much as 13% to record low of A$0.1; set for weakest trading session since October 2024** Medical tech firm says a former employee filed litigation in the U.S., alleging breaches of fiduciary duties and mismanagement against several employees** Litigation makes several claims - that certain tech has not been approved by U.S. FDA and that co did not take sufficient measures to address safety concerns about the use of its surgical solution in breast implant procedures** Co says its products are safe, effective and FDA-approved** Stock fell 66.2% in 2024 (Reporting by Manasi Dasa Sundeep in Bengaluru) ((manasi.dasasundeep@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}